Tuesday, April 01 14:45:58
US-based pharmaceutical group, Regeneron, is now likely to press ahead with its plans to invest E220m in to building a processing plant at its former Dell plant in County Limerick with the creation of around 300 jobs.
The plan had been on hold because An Taisce has withdrawn its objections over the site, which stemmed from traffic and parking concerns.
The proposed $300 million investment programme will involve the major refurbishment of existing buildings on the site (vacant since 2009) and the construction of a quality control laboratory, which will transform the site into a world-class biopharmaceutical campus. Subject to a successful permit, construction and refurbishment is anticipated to begin in 2014 for a two-year period, generating up to 600 temporary construction jobs for local contractors.
"Regeneron is one of the largest and fastest-growing biopharmaceutical companies in the United States," said Daniel Van Plew, Regeneron's Senior VP & GM of Industrial Operations and Product Supply. "Pending planning approval, Limerick will become our second industrial production site, expanding our manufacturing capacity into Europe and facilitating the delivery of a growing supply of medicines for patients worldwide."
Van Plew continued, "Ireland has a highly educated work force and a strong biopharma industry while the Irish Government has an unparalleled commitment to education and training for pharmaceutical manufacturing, quality assurance, quality control and supply logistics. We hope to work with the National Institute for Bioprocessing Research & Training (NIBRT) and are already in discussions with the universities and colleges in Limerick about future possibilities. We see Limerick as a good place to do business - the area has excellent educational institutes, a strong community spirit and a solid transport infrastructure. We are grateful to IDA Ireland for its support in helping us secure this facility and we look forward to playing an active role in Ireland's biopharma sector and building strong relationships with key stakeholders."